Onyx Bridge Wealth Group LLC Akebia Therapeutics, Inc. Transaction History
Onyx Bridge Wealth Group LLC
- $560 Million
- Q1 2024
A detailed history of Onyx Bridge Wealth Group LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Onyx Bridge Wealth Group LLC holds 15,000 shares of AKBA stock, worth $14,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 12,500
20.0%
Holding current value
$14,250
Previous $15,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AKBA
# of Institutions
127Shares Held
56.7MCall Options Held
937KPut Options Held
743K-
Satter Management Co., L.P.13.2MShares$12.5 Million26.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$7.81 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA5.31MShares$5.04 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.65MShares$3.47 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.1 Million0.0% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $175M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...